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ProopiomelanocortinIntracerebroventricular injection of oxytocin (Oxt), a neuropeptide produced in hypothalamic
paraventricular (PVN) and supraoptic nuclei (SON), melanocortin-dependently suppresses feeding.
However, the underlying neuronal pathway is unclear. This study aimed to determine whether
Oxt regulates propiomelanocortin (POMC) neurons in the arcuate nucleus (ARC) of the hypothala-
mus. Intra-ARC injection of Oxt decreased food intake. Oxt increased cytosolic Ca2+ in POMC neurons
isolated from ARC. ARC POMC neurons expressed Oxt receptors and were contacted by Oxt termi-
nals. Retrograde tracer study revealed the projection of PVN and SON Oxt neurons to ARC. These
results demonstrate the novel oxytocinergic signaling from PVN/SON to ARC POMC, possibly regulat-
ing feeding.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Food intake is regulated by neurons within the hypothalamus of
the brain [1]. The arcuate nucleus (ARC) is a key hypothalamic
region involved in food intake regulation [2,3]. There are two known
distinct populations of ARC neurons that regulate food intake and
energy expenditure, being recognized as the ﬁrst order neurons
[1]. One is the neurons that express neuropeptide Y (NPY)/agouti-
related peptide (AgRP) [4], and the other is the neurons that express
pro-opiomelanocortin (POMC)/cocaine and amphetamine-regu-
lated transcript (CART) [1,5]. a-MSH, derived from POMC, reduces
food intake and stimulates energy expenditure via activation of
melanocortin 3 and 4 receptors (MC3/4R) [6]. The ARC POMC neu-
rons project to the neurons in the paraventricular nucleus (PVN),
the second order neurons, where MC3/4R are abundantlyexpressed. Mutations in POMC andMC3/4R genes cause rare mono-
genic human obesity syndromes associated with hyperphagia [7].
These observations reemphasize the importance of POMC neurons
and downstream melanocortin pathway in maintaining the proper
body weight and food intake. Therefore, elucidation of regulatory
mechanism of ARC POMC neurons is prospectively important both
in the physiology of energy balance and for the treatment of obesity.
Although several regulators of ARC POMC neuron activity, such as
leptin, insulin and 5-HT, have been reported [8], other yet unidenti-
ﬁed regulatory factors might also be involved.
Oxytocin (Oxt) is a profoundly recognizedneurophysial hormone
with important peripheral functions including the uterus contrac-
tion during labor and milk ejection [9]. In addition, recent studies
have indicated important functionsofOxt in the central nervous sys-
tem (CNS) such as social [10,11] andmaternal behavior [12]. Among
the reported effects of Oxt in CNS, the capability of Oxt to regulate
food intake and energy metabolism attracts the great interest. Oxt
is expressed predominantly in PVN and supraoptic nucleus (SON)
of the hypothalamus. Intracereberoventricular (ICV) injection of
Oxt suppresses food intake in a melanocortin-dependent manner
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innervate and directly regulate POMC neurons in the nucleus of
the solitary tract (NTS) and that the neural pathway from PVN Oxt
to NTS POMC neurons mediates the anorexigenic effect of nesfa-
tin-1 [14]. However, possible link of Oxt neurons to the POMC neu-
rons in ARC remains unclear.
In this study we aimed to explore whether the PVN and/or SON
Oxt neurons regulate the ARC POMC neurons. The results show
that Oxt is a new regulator of ARC POMC neurons and that the
PVN and SON Oxt neurons project to ARC POMC neurons.Fig. 1. Lateral ventricle (LV) injection of Oxt suppresses food intake and induces c-Fos e
cumulative (A) and periodical (B) food intake after LV injection of vehicle (0.9% NaCl: o
groups. ⁄P < 0.05. ⁄⁄P < 0.01 vs. control by repeated measures two-way ANOVA by T
immunostaining in arcuate nucleus (ARC) after LV injection of saline ((C) n = 3) or 4 nm
neurons/section in ARC after injection of 4 nmol Oxt (ﬁlled bar) or 5 ll vehicle (open bar)
food intake for 1–24 h after focal injection of vehicle (0.9% NaCl: open bar) or Oxt (0.4 nm
vs. control by repeated measures two-way ANOVA by Turkey’s post hoc test.2. Materials and methods
2.1. Animals
Adult male Wistar rats, transgenic rats bearing an Oxt-mono-
metric red ﬂuorescent protein 1(mRFP1) fusion transgene [15]
(200–250 g body weight), and knock-in mice expressing the ﬂuo-
rescent venus protein under the control of endogenous regulatory
region of Oxt receptor (Oxt-R) (Oxt-R venus mouse: approximately
30 g BW) [16] were housed under 12 h dark/light cycle (lights on atxpression in ARC, and intra-ARC injection of Oxt suppresses food intake. (A and B)
pen bar) or Oxt (ﬁlled bar) (4 nmol/5 ll). n = 10 for control and 10 for Oxt injected
urkey’s post hoc test. (C and D) The representative microphotographs of c-Fos
ol Oxt ((D) n = 3). Scale bars indicate 100 lm. (E) Number of c-Fos immunoreactive
. ⁄⁄P < 0.01 vs. control by unpaired t-test. (F and G) Cumulative (F) and periodical (G)
ol/0.5 ll: ﬁlled bar) into ARC (n = 8 each). Each bar represents mean ± S.E. ⁄⁄P < 0.01
4406 Y. Maejima et al. / FEBS Letters 588 (2014) 4404–441207:30 and off at 19:30) and temperature controlled (22 C) condi-
tions and given standard chow (CE-2; Clea, Osaka, Japan) and water
ad libitum. The animal protocols were approved by the Jichi Medi-
cal University Institute of Animal Care and Use Committee.
2.2. ICV and intra-ARC cannulation and measurements of food intake
Rats were anesthetized by intraperitoneal (ip) injection of Aver-
tin (tribromoethanol, 200 mg/kg, ip). For ICV injection, a 26-gauge
guide cannula was placed stereotaxically into the lateral ventricle
(LV) (0.8 mm caudal to the bregma, 1.5 mm lateral from the mid-
line and 3.2 mm below the surface of the skull). For intra-ARC
injection, the cannula was inserted into the ARC (3 mm caudal to
the bregma in the midline, 0.3 mm lateral and 9.0 mm below the
surface of the skull). The injector needle extended by 0.6 mm
beyond the tip of the guide cannula for the LV and intra ARC injec-
tion. Rats were allowed to recover from the operation at least for
10 days while they were habituated to handling.
On the day of experiments, food was removed from individual
cage 3 h before onset of dark phase. Injection of Oxt into LV
(4 nmol/5 ll) or ARC (0.4 nmol/0.5 ll) were performed just before
onset of dark phase, and cumulative food intake 1, 3, and 6 h for LV
injection and 1, 2, 3, 12 and 24 h for intra ARC injection were mea-
sured. To prevent spillage from food container, new chows larger
enough compared to slits on container were provided at the begin-
ning of experiment. At the end of the experiments, sections of the
hypothalamus were histologically examined to verify the positionFig. 2. Oxt induces c-Fos expression in ARC POMC neurons. (A and B) Representative ima
((A) n = 3) or 4 nmol Oxt ((B) n = 3). Scale bars indicate 100 lm and those in separated p
ARC POMC neurons after LV injection of 4 nmol Oxt (ﬁlled bar) or 5 ll vehicle (open bar)
4 nmol Oxt (ﬁlled bar: n = 3) or 5 ll vehicle (open bar: n = 4). Each bar represents meanof the cannulas. LV cannulation was successful in all animals.
Intra-ARC cannulation was unsuccessful in four rats and these ani-
mals were excluded from the study.
2.3. Staining for c-Fos, POMC, and agouti-related peptide (AgRP)
Animals were deprived of food 3 h before onset of dark cycle
until the transcardial perfusion. Animals received injections into
the LV with either 4 nmol/5 ll Oxt (n = 3) or 5 ll vehicle (n = 3) just
before the onset of dark cycle. Two hours later, rats were transcar-
dially perfused with 4% paraformaldehyde solution containing 0.2%
picric acid. Coronal sections having thickness of 40 lm were cut
with the help of a freezing microtome. Sections at 200 lm intervals
between 1.7 and 3.3 mm from the bregma were used for
immunohistochemistry. For c-Fos staining, anti-c-Fos antiserum
(1:5000, sc-52; Santa Cruz, CA) was used following previous
report [17].
Double-labeling immunohistochemistry for c-Fos with POMC or
AgRP was performed as reported [14]. Rabbit anti-POMC serum
(1:5000) [18] or anti-AgRP serum (Phoenix pharmaceuticals Inc.
CA, 1:500) was used as the ﬁrst antibody. The number of c-Fos
immunoreactive (IR) cells per section was counted for the ARC
between 1.7 and 3.3 mm from bregma. The count in a section
was averaged for all sections in ARC in each animal, yielding an
individual datum. For double immunostaining, c-Fos-IR cells,
POMC- or AgRP-IR cells, and dually IR cells were counted in the
sections containing ARC. The fraction of c-Fos-IR cells inges of double immunostaining of c-Fos and POMC in ARC after LV injection of saline
ictures with large magniﬁcation 10 lm. (C) Percentage of c-Fos positive neurons in
. (D) Percentage of c-Fos positive neurons in ARC AgRP neurons after LV injection of
± S.E. ⁄P < 0.05 compared to control by unpaired t-test.
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sections.2.4. Observation of oxytocin receptors in POMC neurons in ARC
Oxt-R venus mice [16] were perfused with 4% paraformalde-
hyde (PFA) in 0.1 M phosphate buffer (PB). Coronal 40 lm sections
between 1.34 mm to 1.94 mm from bregma were incubated
overnight with rabbit anti-POMC serum [18] diluted 1:5000 at
4 C. Then sections were incubated with Alexa 594 goat anti-rabbit
IgG (Molecular Probes, Carlsbad, CA; 1:500). Confocal ﬂuorescence
images were acquired with a confocal laser-scanning microscope
(Fluoreview FV1000-TO; Olympus, Tokyo Japan).2.5. Preparation of single neurons from ARC
Single neurons from male Wistar rats aged 6 weeks were pre-
pared from ARC according to previous reports [19,20] with slight
modiﬁcation. Brieﬂy, brain slices were prepared and the entire
ARC areas were punched out in Krebs-Ringer bicarbonate buffer
solution (KRB). The tissues were incubated with 20 units/ml
papain (Sigma Chemical, St. Louis, MO), 1 mM cystein,
0.015 mg/ml deoxyribonuclease and 0.75 mg/ml BSA in KRB
containing 1 mM glucose for 15 min at 36 C in a shaking water
bath. Following gentle trituration, the cell suspension was washed
with KRB by centrifugation at 750 rpm for 5 min. The cells were
re-suspended in KRB and distributed onto non-coating cover-
glasses. The cells were kept in a humidiﬁed chamber at 30 C
until measurements.Fig. 3. The expression of Oxt receptor (Oxt-R) in POMC neurons in ARC. (A) Distribution
indicate neurons double positive for Oxt-R and POMC. (C) Merged image of (A) and (B). S
neurons. (E) Percentage of POMC neurons in Oxt-R positive neurons.2.6. Measurement of [Ca2+]i and subsequent immunocytochemistry in
single neurons
We used the method of physiological analysis of species-
speciﬁed single cells [21], which is composed of [Ca2+]i measure-
ments and subsequent immunostaining. [Ca2+]i was measured by
ratiometric fura-2 microﬂuorometry and imaging as previously
reported [20,22]. Brieﬂy, neurons were incubated with 2 lM
fura-2/AM (Dojin chemical, Kumamoto, Japan) for 1 h at room tem-
perature. Then, the neurons were mounted in a chamber and
superfused with KRB at 1 ml/min at 33 C. Fluorescence images
due to excitation at 340 and 380 nmwere detected with ICCD cam-
era, and the ratio images were produced by Argus-50 (Hamamatsu
Photonics Co., Hamamatsu, Japan).
For immunocytochemistry after [Ca2+]i measurements, single
neuronswereﬁxed in4%PFA for overnight, and then incubatedover-
nightwith rabbit antiserum against POMC [18] at 1:5000 dilution at
4 C, following previous reports [20,22]. [Ca2+]i result of each cell
was correlated with its corresponding immunocytochemical result,
based on photographs of cells taken at the end of [Ca2+]i imaging.
2.7. Criteria for [Ca2+]i responses and their inhibition
When changes in ratio (F340/F380) took place within 5 min
after administration of agents and their amplitudes were 0.4 ratio
unit or larger, they were considered as responses, as previously
reported [14,17,20]. When Oxt-R antagonist, H4928 ([d(CH2)51,
Tyr(Me)2, Orn8]-Oxt) (Bachem, Budendorf, Switzerland), sup-
pressed the Oxt-induced [Ca2+]i increase by 40% or greater, it was
considered as suppression. Amplitudes of [Ca2+]i responses wereof Oxt-R and (B) POMC neurons in ARC of Oxt-R-venus knock in mice. White arrows
cale bars indicate 10 lm. (D) Percentage of Oxt-R positive neurons in POMC positive
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2.8. Projection of Oxt terminal to ARC POMC neurons
Oxt-mRFP rats were anesthetized by ip injection of Avertin (tri-
bromoethanol, 200 mg/kg) before brains were removed. The brain
sections between 1.78 and 3.25 mm from bregma were pre-
pared. Sections were incubated with primary antibody, rabbit
anti-POMC antiserum (1:5000) [18] for overnight at 4 C, followed
by incubation for 40 min with secondary antibodies, Alexa 488
goat anti-rabbit IgG (Molecular Probes, Carlsbad, CA; 1:500). Sec-
tions were mounted with the medium containing DAPI (VECTA-
SHIELD; Vector, CA). Confocal ﬂuorescence images were acquired
with a confocal laser-scanning microscope (Fluoreview FV1000-
TO; Olympus, Tokyo, Japan).
2.9. Injection of retrograding tracer
A retrograde tracer, cholera toxin subunit B Alexa Fluor 488
(CTB: Invitrogen, CA), was used to identify the pathwayFig. 4. Oxt induces [Ca2+]i increases in ARC POMC neurons via Oxt-R. (A) Oxt at 1010 M i
107 M (left panel) in a neuron isolated from adult male rat. Superfusates contained 1 m
(right panel). Scale bar = 10 lm. (B) Incidence of [Ca2+]i responses to Oxt in ARC POMC neu
absence (white bar) and presence of H4928 (black bar). ⁄⁄P < 0.01 by paired t-test.connecting ARC and PVN Oxt neurons in Oxt-mRFP rats. CTB,
0.5 ll of 0.5 mg/ml, was acutely injected into unilateral ARC
(3 mm caudal to the bregma, 0.3 mm lateral from midline and
9.4 mm below the surface of the skull) under anaesthesia. Simi-
larly, CTB was injected into median eminence (ME: 3 mm caudal
to the bregma in the midline and 9.8 mm below the surface of
the scull). Four days after injection of CTB, animals were per-
fused with 4% PFA containing 0.2% picric acid. Brain sections
were made by cutting in freezing microtome. Confocal
ﬂuorescence images of Oxt and CTB labels were acquired with
a confocal laser-scanning microscope (Fluoreview FV1000-TO;
Olympus, Tokyo, Japan). Accuracy of injection was conﬁrmed
histologically.
2.10. Statistical analysis
Data are expressed as means ± S.E. Data were analyzed by
unpaired or paired Student’s t test or by repeated measures two-
way ANOVA with treatment (saline vs. Oxt) and time as factors.
Post hoc multiple comparisons were made using Turkey’s post
hoc test. P < 0.05 was considered signiﬁcant.ncreased [Ca2+]i, and the [Ca2+]i increase was suppressed by Oxt-R blocker H4928 at
M glucose. This neuron was subsequently shown to be immunoreactive to POMC
rons, as expressed by percentage. (C) The amplitude of [Ca2+]i response to Oxt in the
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3.1. Oxt targets ARC POMC neurons
LV Oxt injection signiﬁcantly reduced cumulative food intake
(F1,36 = 63.24, P < 0.01) (Fig. 1A) and periodical food intake
(F1,36 = 4.11, P < 0.01) (Fig. 1B). Periodical food intake during 0–
1 h, 1–3 h and 3–12 h in Oxt-treated group was 38% (P < 0.01),
110% and 77% (P < 0.05) of that in control group, respectively. LV
Oxt injection signiﬁcantly induced c-Fos expression in the ARC of
hypothalamus (Fig. 1C–E), suggesting that ARC is targeted by Oxt.
Furthermore, intra-ARC injection of Oxt signiﬁcantly reduced
cumulative food intake at 1 and 12 h after injection (F1,56 = 18.47,
P < 0.01) (Fig. 1F), and periodical food intake during 0–1 h tended
to decrease (Fig. 1G). Periodical food intake during 0–1 h, 1–2 h,
2–3 h, 3–12 h and 12–24 h in Oxt-treated group was 50%, 145%,
85%, 95% and 187% of that in control group, respectively (not statis-
tically signiﬁcant in all time periods). These results indicate that
anorexigenic effect of LV Oxt injection is greater than that of
intra-ARC Oxt injection, suggesting that ARC activation mediates
a part, but not all, of food intake reduction by LV Oxt injection.
The LV injection of Oxt, compared to vehicle injection, signiﬁ-
cantly increased c-Fos expression in ARC POMC (Fig. 2A and B)
and AgRP neurons. The expression of c-Fos was observed in
14.7% of POMC neurons in Oxt injected group, compared to 4.1%
in control group (Fig. 2C). C-Fos expression was also observed
18.5% and 8.0% of AgRP neurons in Oxt injected and control groups,
respectively (Fig. 2D). These data indicate that POMC neuron is one
of the neurons inﬂuenced by Oxt in ARC.
3.2. ARC POMC neurons express Oxt-R and are directly activated by
Oxt
To study the localization of Oxt receptors in ARC POMC neu-
rons, we used Oxt-R venus mice [16] combined with immuno-
histochemistry for POMC. Oxt-R were widely distributed inFig. 5. The terminal of Oxt contact to ARC POMC neurons. (A) Confocal images of POMC-I
images of (A)–(C) in ARC of Oxt-mRFP rats. White arrow heads indicate the contact of OARC (Fig. 3A). Confocal images conﬁrmed that a large number
of POMC-immunoreactive (IR) neurons express Oxt-R (Fig. 3A–
C). Fifty percent of POMC-IR neurons expressed Oxt-R
(Fig. 3D), and 55% of Oxt-R-expressing neurons were POMC-IR
neurons (Fig. 3E).
Administration of 1010 M Oxt increased [Ca2+]i in a single ARC
neuron (Fig. 4A, left) that was subsequently shown to be IR to
POMC (Fig. 4A, right). A large fraction of the neurons (11/18) that
responded to Oxt were POMC-IR neurons (Fig. 4B). The [Ca2+]i
increase in response to Oxt was signiﬁcantly suppressed by admin-
istration of OxtR-antagonist, H4928 (Fig. 4A and C).
3.3. PVN and SON Oxt neurons project to ARC POMC neurons
Confocal images of immunostaining of POMC neurons (Fig. 5A)
in Oxt-mRFP rats indicated that the Oxt terminals (Fig. 5B) were in
contact with the POMC neurons in ARC (Fig. 5A–D).
It was conﬁrmed that the retrograde tracer CTB was injected
speciﬁcally into ARC region without signiﬁcant diffusion to other
regions including the ventromedial hypothalamic nucleus (VMH)
(Fig. 6C). The CTB ﬂuorescence was detected speciﬁcally and inten-
sely in ipsilateral PVN and SON on the same side of injection
(Fig. 6D). Few ﬂuorescence was detected in the contralateral side
of PVN and SON (Fig. 6D). In contrast, when CTB was injected into
median eminence (Fig. 6E) with diffusion into 3V (Fig. 6F), no CTB
signals were detected in PVN (Fig. 6G) and SON. The result suggests
that if ARC-injected CTB diffused into 3V, it would have no effect on
the CTB signals in PVN and SON, reinforcing that CTB signals in PVN
and SON originate from ARC. When analyzed at the neuron level,
CTB ﬂuorescence was detected in both parvocellular and magno-
cellular neurons in the PVN (Fig. 6H) and throughout the SON
(Fig. 6N). In PVN, 29% of CTB ﬂuorescence-positive neurons were
identiﬁed as Oxt neurons (Fig. 6H–M and Q), and conversely 27%
of Oxt neurons were CTB ﬂuorescence-positive (Fig. 6H–M and
R). In the SON, 24% of CTB ﬂuorescence-positive neurons were
Oxt neurons (Fig. 6N–Q), and 21% of Oxt neurons were CTBR neurons, (B) Oxt terminals, and (C) DAPI nuclear counter staining, and (D) merged
xt terminals to POMC neurons. Scale bars indicate 10 lm.
Fig. 6. Oxt neurons in PVN and SON project to the ARC. (A and B) The brain map of the coronal level including injection sites (A), and larger scale map showing choleratoxin
subunit B (CTB) injection position in ARC (B). Black circles show each injection positions in ARC and red cross shows the position of injection into median eminence (ME) for
negative control. (C) Representative injection site of CTB in ARC. (D) Tracer positive regions in the hypothalamus at 4 days after CTB injection into ARC. Scale bars in (C) and
(D) indicate 100 lm. (E–G) CTB injection site in ME for negative control (E). When CTB was injected to ME with diffusion to 3V, CTB signals were present in ependymal cells
(white arrows) (F) but absent in PVN (G). (H and J) CTB positive neurons (H), Oxt neurons (I), and their merge (J) in PVN. Scale bars indicate 50 lm. (K–M) Areas designated by
white squares in (H)–(J) are shown with expanded scale. Green and red allows indicate CTB and Oxt single-positive neurons, respectively. Yellow arrows indicate CTB and Oxt
double-positive neurons. Scale bars indicate 10 lm. (N–P) CTB positive neurons (N), Oxt neurons (O), and their merge (P) in SON. Green and red allows indicate CTB and Oxt
single-positive neurons, respectively. Yellow arrows indicate CTB and Oxt double-positive neurons. Scale bars indicate 50 lm. 3V: 3rd ventricle, opt: optic tract. (Q) The
percentage of Oxt neurons among CTB labeled neurons in PVN (open bar) and SON (ﬁlled bar). (R) The percentage of CTB labeled neurons among Oxt neurons in PVN (open
bar) and SON (ﬁlled bar).
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PVN and SON Oxt neurons as the sources of Oxt projection in ARC.
4. Discussion
The present study demonstrated a novel oxytocinergic neural
pathway from the PVN and SON to the ARC POMC neurons, which
could be linked to regulation of feeding.
The important role of Oxt in regulating food intake is well rec-
ognized. Recent studies have clariﬁed the speciﬁc nuclei that are
involved in Oxt-mediated food intake regulation, which include
ventral tegmental area (VTA), PVN, ARC, VMH, amygdala and NTS
[23–25]. Therefore, ARC appears to be one of several nuclei
involved in food intake regulation by Oxt. ICV injection of Oxt
may activate neurons expressing Oxt-R in all the reported nuclei
whereas intra-ARC injection activate only those in ARC. This could
explain our result that ICV injection of Oxt reduced food intake to a
larger extent than intra-ARC injection.
It is evident that ARC neurons are one of the key factors for the
Oxt-mediated food intake regulation [25]. In the present study, we
have identiﬁed a chemical coding of neurons in ARC activated by
Oxt and projection of Oxt neurons to ARC from PVN and SON.
Immunostaining of POMC neurons in Oxt-R venus mice demon-
strated that POMC neurons in ARC express Oxt-R. Moreover, the
[Ca2+]i measurement in single neurons combined with subsequent
immunocytochemistry demonstrated that Oxt directly interacts
with and increases [Ca2+]i in ARC POMC neurons and that the
[Ca2+]i increases are suppressed by Oxt-R antagonist, H4928. These
results indicate that Oxt directly activates ARC POMC neurons via
Oxt-R. In this study, 60% of single PVN neurons that responded to
Oxt were identiﬁed as POMC neurons, and this incidence is close
to that of POMC neurons among Oxt-R positive neurons in ARC
(55%). These Ca2+ imaging and histological data support the con-
cept that the POMC neuron is a major target of Oxt in ARC.
In this study, the immunostaining of POMC neurons in the ARC
of Oxt-mRFP rats conﬁrmed that Oxt neuron terminals contact the
POMC neurons in ARC. This is consistent with previous report by
electron microscopic observation that the Oxt nerve ﬁbers inner-
vate the neurons IR to b-endorphin, the POMC-derived peptide,
in ARC [26].
Recently, it was reported that POMC neurons in the ARC and
those in the NTS play different roles in regulating food intake
[27]; ARC POMC neurons long-termly while NTS POMC short-term-
ly regulate feeding. However, our present and previous studies [14]
taken together indicate that PVN Oxt neurons regulate POMC neu-
rons in both NTS and ARC.
The histological study using retrograde tracer CTB [28] have
shown that Oxt neurons in PVN and SON project to ARC. The inten-
sive histological studies in 1980s established that a population of
PVN Oxt neurons termed magnocellular neurons send axon termi-
nals to the pituitary gland, being recognized as the neuroendocrine
function, and the other population termed parvocellular neurons
project to various brain regions [29], while SON neurons send axon
terminals to the pituitary gland. Our ﬁnding that PVN Oxt neurons
project to ARC ﬁts with the classic concept of the parvocellular
neuron in PVN. In considering pivotal roles of both Oxt and POMC
in feeding, the projection of PVN Oxt to ARC POMC might partici-
pate in regulation of feeding. In contrast, our data showing that a
part of SON Oxt neurons also project to ARC suggest a possibility
that a subpopulation of SON neurons operate a novel function of
neurotransmission to ARC and possibly other brain areas. However,
the physiological signiﬁcance of the Oxt neuronal projections from
PVN and SON to ARC POMC neurons, shown in this study, still
remains unclear, and further study is required to clarify it.
In this study, non-POMC neurons in ARC also expressed Oxt-R,
and Oxt altered [Ca2+]i in non-POMC neurons. The neurochemicalidentity of the ARC non-POMC neurons that express Oxt-R and
respond to Oxt remains unclear. Similarly to our study, Krashes
et al. has recently shown that pituitary adenylate cyclase-activat-
ing polypeptide (PACAP) and thyrotropin-releasing peptide (TRH)
positive neurons in PVN project to orexigenic NPY/AgRP neurons
in ARC and are activated by hunger [30]. Our result of c-Fos expres-
sion in AgRP neurons also supports these report. These ﬁndings by
us and by Krashes et al. [30] suggest an involvement of the PVN to
ARC neural pathways in regulation of hypothalamic functions
including feeding.
The present study demonstrates the novel oxytocinergic path-
way from PVN/SON to ARC POMC possibly regulating food intake,
which suggests the neural signaling in the reverse direction, from
the second order PVN Oxt neuron to the ﬁrst order ARC POMC
neuron.Disclosure statement
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